Stability & Regulatory Support
January 24, 2020
ICH Stability program to support semipermeable conditions. Regulatory team supports project throughout regulatory lifecycle.
Analytical & Microbiology Support
January 24, 2020
Dedicated multidisciplinary team to support all aspects of development from method development, method validation, sterility & bioburden along with our robust microbiology lab.
Process Development & Technology Transfer
January 24, 2020
Development engineering teams lead all aspects of product development/transfers from the clinical study stage and manage projects throughout the development lifecycle, process validation & commercial launch.
Recent Posts
- Ritedose Launches New 503B, Single-Dose Syringe Medications for Hospitals: Rocuronium Bromide Injection (50 mg/5mL) and Rocuronium Bromide Injection (100 mg/10mL)
-
The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser
SuredoseRx™ to launch in first quarter - Ritedose Pharmaceuticals Launches Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 ml
-
Novo Holdings to acquire Ritedose:
Novo Holdings A/S (“Novo Holdings”) today announced that it has agreed to acquire Ritedose from AGIC Capital and Humanwell. - Ritedose Pharmaceuticals Launches Budesonide Inhalation Suspension (0.5 mg/2 ml)
Archives
Categories
Recent News
-
-
The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser
SuredoseRx™ to launch in first quarter Posted on 18th January, 2022 -
Ritedose Pharmaceuticals Launches Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 ml Posted on 5th January, 2022
Post Categories
- In the News (11)
- Press Releases (10)
- Uncategorized (8)
Recent Comments